CD69 is an immunoregulatory molecule induced following activation

被引:373
作者
Sancho, D [1 ]
Gómez, M [1 ]
Sánchez-Madrid, F [1 ]
机构
[1] Univ Autonoma Madrid, Hosp Primcesa, Serv Inmunol, E-28006 Madrid, Spain
关键词
D O I
10.1016/j.it.2004.12.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD69 is an early leukocyte activation molecule expressed at sites of chronic inflammation. The precise role of CD69 in immunity has not been elucidated owing to the absence of a known ligand and adequate in vivo models to study its physiological function. Although previous in vitro studies suggest that CD69 is an activatory molecule in different leukocyte subsets, recent studies in CD69-deficient mice have revealed a non-redundant role for this receptor in downregulation of the immune response through the production of the pleiotropic cytokine transforming growth factor-P (TGF-beta). The possible cellular and molecular mechanisms of action of this molecule are discussed herein.
引用
收藏
页码:136 / 140
页数:5
相关论文
共 51 条
  • [1] ACTIVATION EVENTS DURING THYMIC SELECTION
    BENDELAC, A
    MATZINGER, P
    SEDER, RA
    PAUL, WE
    SCHWARTZ, RH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) : 731 - 742
  • [2] Regulating T helper cell immunity through antigen responsiveness and calcium entry
    Bikah, G
    Pogue-Caley, RR
    McHeyzer-Williams, LJ
    McHeyzer-Williams, MG
    [J]. NATURE IMMUNOLOGY, 2000, 1 (05) : 402 - 412
  • [3] TRANSFORMING GROWTH-FACTOR BETA-1 SUPPRESSES ACUTE AND CHRONIC ARTHRITIS IN EXPERIMENTAL-ANIMALS
    BRANDES, ME
    ALLEN, JB
    OGAWA, Y
    WAHL, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) : 1108 - 1113
  • [4] TGF-β receptor controls B cell responsiveness and induction of IgA in vivo
    Cazac, BB
    Roes, J
    [J]. IMMUNITY, 2000, 13 (04) : 443 - 451
  • [5] TRIGGERING OF T-CELL PROLIFERATION THROUGH AIM, AN ACTIVATION INDUCER MOLECULE EXPRESSED ON ACTIVATED HUMAN-LYMPHOCYTES
    CEBRIAN, M
    YAGUE, E
    RINCON, M
    LOPEZBOTET, M
    DELANDAZURI, MO
    SANCHEZMADRID, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (05) : 1621 - 1637
  • [6] Chatenoud L, 1997, J IMMUNOL, V158, P2947
  • [7] Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
    Chen, WJ
    Jin, WW
    Hardegen, N
    Lei, KJ
    Li, L
    Marinos, N
    McGrady, G
    Wahl, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) : 1875 - 1886
  • [8] FUNCTIONAL-CHARACTERIZATION OF AN ANTIGEN INVOLVED IN AN EARLY STEP OF T-CELL ACTIVATION
    COSULICH, ME
    RUBARTELLI, A
    RISSO, A
    COZZOLINO, F
    BARGELLESI, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) : 4205 - 4209
  • [9] TRIGGERING OF HUMAN MONOCYTE ACTIVATION THROUGH CD69, A MEMBER OF THE NATURAL-KILLER-CELL GENE-COMPLEX FAMILY OF SIGNAL-TRANSDUCING RECEPTORS
    DEMARIA, R
    CIFONE, MG
    TROTTA, R
    RIPPO, MR
    FESTUCCIA, C
    SANTONI, A
    TESTI, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) : 1999 - 2004
  • [10] Enhanced antitumor immunity in mice deficient in CD69
    Esplugues, E
    Sancho, D
    Vega-Ramos, J
    Martínez-A, C
    Syrbe, U
    Hamann, A
    Engel, P
    Sánchez-Madrid, F
    Lauzurica, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) : 1093 - 1106